Potential Weak Interaction
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Quality of Evidence:
Coadministration has not been studied. Moxonidine is only minimally metabolized and is eliminated renally by glomerular filtration and active secretion, mainly as unchanged moxonidine. The renal transporter involved in moxonidine excretion is unknown but does not seem to involve P-glycoprotein or renal organic cation (OCT) transporters. No interaction is expected with emtricitabine (eliminated by OCT2), however, an interaction with tenofovir-DF cannot be excluded.
View all available interactions with
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking